How to Price Peptide Therapy Services for Profit and Retention

Pricing is the single most underthought decision in most peptide therapy clinics. Providers either undercharge and destroy their margins, or overcharge and slow patient acquisition. This post presents a pricing framework built for 2026 that protects margins, improves retention, and scales cleanly as the clinic grows.

The floor for any peptide therapy service price is the all-in cost plus a healthy margin. All-in cost includes the peptide itself, any reconstitution or delivery supplies, the provider's clinical time, staff time, overhead allocation, and follow-up time. For most peptide therapy services, all-in cost ranges from $150 to $400 per protocol depending on the peptide and the clinical model. Margin should be at least 3x all-in cost to create a sustainable business.

Market ceiling is the highest price patients will reliably pay in your market. Research local competitors, check published pricing on public clinic websites, and talk to patients during intake about what they have seen elsewhere. The market ceiling is not a universal number. It varies by city, treatment category, and patient demographic.

Your sustainable price lives somewhere between the cost-plus floor and the market ceiling. Most successful peptide therapy clinics price at 70 to 85 percent of the market ceiling. This captures strong margins without pricing themselves out of the market.

Package pricing improves retention and cash flow. A three-month protocol package priced at a 10 percent discount compared to monthly pricing encourages commitment and locks in revenue. Packages also reduce the emotional weight of each individual visit, which improves the patient experience.

Offering a basic, standard, and premium service tier captures patients at multiple price points. Basic might include the peptide and clinical monitoring. Standard might add quarterly lab work. Premium might add genetic testing, personalized coaching, and priority scheduling. Tiered pricing can increase average revenue per patient by 30 to 50 percent without losing volume.

Three pricing mistakes show up repeatedly in peptide therapy clinics. First, copying competitor pricing without running the cost math. Second, discounting aggressively to chase volume. Third, failing to raise prices as clinical outcomes and brand authority grow. Each of these mistakes compounds over time.

Review pricing quarterly. Look at cost trends, competitor movements, patient feedback, and close rates. Adjust prices when the data supports it. Clinics that review pricing regularly tend to capture more margin than clinics that set prices once and forget.